AA
GSK icon

Apriem Advisors’s GSK GSK Stock Holding History

Apriem Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-4,240
Closed -$223K – 295
2017
Q1 		$223K Sell
4,240
-570
-12% -$28.9K 0.06% 116
2016
Q4 		$232K Sell
4,810
-14,980
-76% -$740K 0.07% 112
2016
Q3 		$1.07M Buy
19,790
+5,040
+34% +$276K 0.32% 51
2016
Q2 		$799K Buy
14,750
+1,780
+14% +$93.8K 0.26% 58
2016
Q1 		$657K Buy
12,970
+1,420
+12% +$70.7K 0.26% 57
2015
Q4 		$583K Buy
11,550
+1,160
+11% +$59.1K 0.21% 61
2015
Q3 		$499K Sell
10,390
-1,514
-13% -$78.8K 0.18% 65
2015
Q2 		$620K Buy
11,904
+1,842
+18% +$104K 0.21% 68
2015
Q1 		$580K Buy
10,062
+9,632
+2,240% +$552K 0.2% 66
2014
Q4 		$23K Sell
430
-301
-41% -$16.8K 0.01% 277
2014
Q3 		$42K Buy
731
+253
+53% +$15.5K 0.02% 222
2014
Q2 		$32K Buy
478
+48
+11% +$3.25K 0.01% 235
2014
Q1 		$29K Hold
430
– – 0.01% 264
2013
Q4 		$29K Hold
430
– – 0.01% 256
2013
Q3 		$27K Sell
430
-160
-27% -$10.3K 0.01% 253
2013
Q2 		$37K Buy
+590
New +$37.4K 0.02% 218

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Apriem Advisors's GSK Position: Q2 2017 in Review

Apriem Advisors sold out of GSK (GSK) in Q2 2017, closing a stake of 4,240 shares — an estimated $223K sold.

Apriem Advisors first reported a position in GSK in Q2 2013 and held it in 16 quarters. The position peaked at $1.07M in Q3 2016. 779 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

  • Apriem Advisors reported no remaining GSK position as of Q2 2017 after selling out during the quarter.
  • Apriem Advisors sold 4,240 GSK shares in Q2 2017, an estimated $223K.
  • Apriem Advisors first reported a position in GSK in Q2 2013 and held it in 16 quarters.
  • Apriem Advisors's GSK position peaked at $1.07M in Q3 2016.
  • 779 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on Apriem Advisors's 13F filing for Q2 2017, filed 4 Aug 2017.